Perez, Melanie, Jaundoo, Rajeev, Hilton, Kelly et al. · Frontiers in pediatrics · 2019 · DOI
Researchers analyzed the DNA of 383 ME/CFS patients to look for genetic variations that might make someone more susceptible to developing the illness. They found thousands of genetic differences that were more common in ME/CFS patients compared to the general population, and these differences clustered in three main areas: immune system function, hormone regulation, and metabolism. While this suggests genetics may play a role in ME/CFS vulnerability, it doesn't explain the entire cause of the disease.
This study provides preliminary evidence that genetic predisposition may contribute to ME/CFS pathogenesis, suggesting biological vulnerability rather than purely psychological origins. Understanding genetic risk factors could eventually lead to better patient stratification, early identification of at-risk individuals, and targeted therapies addressing underlying immune and metabolic dysfunction.
This study does not establish that these genetic variants cause ME/CFS—it only shows associations in one cohort. The findings have not been validated in independent populations, and the presence of a genetic variant does not determine whether someone will develop the disease. Additionally, this pilot study cannot explain how genetic variants trigger illness onset or why environmental factors appear necessary for disease development.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.